Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

KAN0438757

Copy Product Info
🥰Excellent
Catalog No. T11741Cas No. 1451255-59-6

KAN0438757 is a selective and potent inhibitor of the metabolic kinase [PFKFB3] with an IC50 of 0.19 μM.

KAN0438757

KAN0438757

Copy Product Info
🥰Excellent
Purity: 99.34%
Catalog No. T11741Cas No. 1451255-59-6
KAN0438757 is a selective and potent inhibitor of the metabolic kinase [PFKFB3] with an IC50 of 0.19 μM.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$103In StockIn Stock
5 mg$202In StockIn Stock
10 mg$323In StockIn Stock
25 mg$583In StockIn Stock
50 mg$801In StockIn Stock
100 mg$1,090In StockIn Stock
1 mL x 10 mM (in DMSO)$217In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.34%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

KAN0438757 AI Summary
KAN0438757 exhibits bioactivity as an inhibitor of PFKFB3 in human NUGC-3, MIA PaCa-2, and PANC-1 cells, resulting in decreased production of Fructose-2,6-Bisphosphate with an IC50 value of 90.0 nM across these cell lines..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
KAN0438757 is a selective and potent inhibitor of the metabolic kinase [PFKFB3] with an IC50 of 0.19 μM.
Targets&IC50
PFKFB3:0.19 μM
Chemical Properties
Molecular Weight447.43
FormulaC21H18FNO7S
Cas No.1451255-59-6
SmilesOCCOC(=O)c1ccc(NS(=O)(=O)c2cccc(c2)-c2cc(F)ccc2O)cc1O
Relative Density.1.507 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 130 mg/mL (290.55 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (7.38 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.2350 mL11.1749 mL22.3499 mL111.7493 mL
5 mM0.4470 mL2.2350 mL4.4700 mL22.3499 mL
10 mM0.2235 mL1.1175 mL2.2350 mL11.1749 mL
20 mM0.1117 mL0.5587 mL1.1175 mL5.5875 mL
50 mM0.0447 mL0.2235 mL0.4470 mL2.2350 mL
100 mM0.0223 mL0.1117 mL0.2235 mL1.1175 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy KAN0438757 | purchase KAN0438757 | KAN0438757 cost | order KAN0438757 | KAN0438757 chemical structure | KAN0438757 formula | KAN0438757 molecular weight